Cross-Match as an Immuno-Oncological Risk Factor for Hepatocellular Carcinoma Recurrence and Inferior Survival After Living Donor Liver Transplantation: A Call for Further Investigation

BACKGROUND: The success of immunotherapy for patients with hepatocellular carcinoma (HCC) suggests that immune dysregulation occurs in HCC patients. This warrants an immuno-oncological risk assessment in the platform of liver transplantation. METHODS: This retrospective single-center study analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Cheng-Maw, Hu, Rey-Heng, Wu, Yao-Ming, Ho, Ming-Chih, Lee, Po-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731698/
https://www.ncbi.nlm.nih.gov/pubmed/33343205
http://dx.doi.org/10.1177/1179554920968774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731698/
https://www.ncbi.nlm.nih.gov/pubmed/33343205
http://dx.doi.org/10.1177/1179554920968774

Ejemplares similares